ClinicalTrials.gg
RecruitingNCT07936461Updated Nov 13, 2026

Feasibility of Occupation-Based Immersive Virtual Reality for Upper-Limb Rehabilitation After Stroke

An interventional study of Occupation-Based Immersive Virtual Reality Rehabilitation in Stroke and Upper Extremity Paresis, sponsored by Democritus University of Thrace. Recruiting at 2 sites in Greece. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2026-11-13.

Sponsored by Democritus University of Thrace · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 9 months after the study started (first participant enrolled Jan 2026, registered Nov 2026).
  • Started Jan 2026; still recruiting 10 months later.
Updated Nov 13, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
18 Years to 90 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-16

Among 55 studies in Stroke with a site in Greece — 13 open to participants now, 18 under way, 3 of them phase 3. Stroke · Greece.

Planned enrollment
40th of 44
20 · median 920
Started
2026
with 2 others
No phase
19 of 55
10 open now
Primary completion
2027-07
later than 11 of 17 live
Registered
55th of 55
by date

Among the 55 studies in Stroke with a site in Greece, this one is the 40th largest by planned enrollment of the 44 interventional ones that give a count, is one of 3 that started in 2026, is one of 19 with no phase, reaches primary completion later than 11 of the 17 other live ones, and was the 55th registered.

Stroke

8,269 studies on the registry are indexed under Stroke; 2,062 are open to participants now.

Browse Stroke studies →

Open to participants now

13 of the 55 studies in Stroke with a site in Greece are open now. Recruiting first, the newest first:

7 more — sign in →

All 13 open studies →

A study can be open while its sites in Greece have not opened yet or have stopped. Only those recruiting at a site in Greece →

Who these studies take

Of the 1,418 Stroke studies recruiting now, 696 (49%) set no upper age limit and 282 (20%) stop at 75 or younger; 77 take children under 18; 196 take healthy volunteers.

This study: 18 Years to 90 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 55 studies in Stroke with a site in Greece, or all of them as a file.
02

Study summary

This ongoing, single-group pilot feasibility study aims to evaluate the feasibility, usability, and acceptability of an occupation-based immersive virtual reality (IVR) rehabilitation program for adults with stroke-related upper-limb impairment. The study has an anticipated enrollment of 20 participants, of whom eight were enrolled during the initial recruitment period.

The intervention consists of 12 supervised sessions per participant, each including approximately 30 minutes of virtual activities delivered through two custom-developed IVR applications, Virtual Gardening and Virtual Painting, using a Meta Quest 2 head-mounted display (HMD). The intervention is provided as an adjunct to usual occupational therapy.

The study examines intervention completion, session delivery, gameplay duration, technical interruptions, safety, user satisfaction, symptoms associated with virtual reality exposure, and participation during rehabilitation sessions. Upper-limb motor function and independence in activities of daily living are also assessed as exploratory clinical outcomes.

The primary aim is to determine whether this occupation-based IVR rehabilitation program can be feasibly implemented in clinical practice and to identify areas for improvement before larger-scale studies. The study is not designed to establish the effectiveness of the intervention compared with conventional rehabilitation.

Read the detailed description

The intervention was developed through a stakeholder-informed process that incorporated occupational therapists' perspectives, stroke survivors' activity preferences, task-level characterization, and preliminary usability evaluation. Two custom-developed IVR applications, Virtual Gardening and Virtual Painting, were implemented using Unity and delivered through a Meta Quest 2 HMD.

This ongoing, single-group pilot feasibility study has an anticipated enrollment of 20 adults with stroke-related upper-limb impairments. Eight participants were enrolled during the initial recruitment period, and recruitment is continuing toward the planned sample size. Participants are scheduled to receive 12 supervised IVR sessions as an adjunct to their usual occupational therapy.

Each session is planned to include approximately 30 minutes of virtual activities: 10 minutes of structured Gardening, 10 minutes of structured Painting, 5 minutes of free Gardening, and 5 minutes of free Painting. Rest breaks and therapist assistance are provided according to individual needs.

The applications include graded activities involving reaching, object interaction, upper-limb coordination, and creative engagement. Different interaction modes, including affected-hand interaction and mirrored control using the unaffected hand, are available to accommodate individual functional abilities. All activities are performed in a seated position under therapist supervision.

Exploratory clinical outcomes include upper-limb motor impairment, assessed using the Fugl-Meyer Assessment for the Upper Extremity (FMA-UE), and independence in activities of daily living, assessed using the Barthel Index. Both measures are administered at baseline (before the first intervention session) and after completion of session 12.

User satisfaction and experience are assessed using the User Satisfaction Evaluation Questionnaire (USEQ), while symptoms associated with virtual reality exposure are monitored using the Simulator Sickness Questionnaire (SSQ). Both questionnaires are administered after intervention sessions 1, 6, and 12.

Participation during rehabilitation is assessed by the therapist using the Pittsburgh Rehabilitation Participation Scale (PRPS) during each intervention session (sessions 1-12).

The study is conducted in supervised rehabilitation settings in Larissa, Greece. Its primary purpose is to examine the feasibility, usability, safety, and acceptability of the occupation-based IVR intervention and to inform the design of future larger-scale investigations. As a single-group pilot feasibility study without a control group, it is not designed to establish treatment efficacy or comparative effectiveness against conventional rehabilitation.

03

Conditions studied

  • Stroke
  • Upper Extremity Paresis

Browse trials for

Keywords

  • Immersive Virtual Reality
  • Stroke Rehabilitation
  • Upper Limb Rehabilitation
  • Occupational Therapy
  • Feasibility Study
  • Virtual Gardening
  • Virtual Painting
04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Confirmed diagnosis of ischemic or hemorrhagic stroke.
  • Age between 18 and 90 years.
  • First-ever or recurrent stroke associated with acquired motor impairment of the upper limb.
  • Stroke occurring at least 2 months before enrollment.
  • Sufficient cognitive and communicative ability to understand study instructions and complete the questionnaires, defined as a (MMSE) score of 24 or higher.
  • Ability to safely participate in an immersive virtual reality (IVR) session using the Meta Quest 2.
  • Greek as the participant's primary language.

Exclusion criteria

Exclusion Criteria:

  • Need for continuous medical monitoring or medical care that could not be safely accommodated during study procedures.
  • Active medical conditions that could interfere with participation or safe IVR exposure, including acute fractures, active skin ulcers, uncontrolled cardiovascular, circulatory, hepatic, or renal conditions, and other unstable comorbidities.
  • Epilepsy or a history of seizures considered clinically relevant to IVR exposure.
  • Uncontrolled diabetes mellitus or hypertension.
  • Active requiring urgent treatment.
  • Severe aphasia or other communication impairments preventing the participant from understanding instructions or completing study questionnaires.
  • Significant visual impairment incompatible with the use of the Meta Quest 2.
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

Clinically significant

Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    Occupation-Based Immersive Virtual Reality Rehabilitation

    Participants receive a 12-session, therapist-supervised, occupation-based IVR rehabilitation program as an adjunct to conventional occupational therapy. The program includes two custom-developed virtual activities, Virtual Gardening and Virtual Painting, delivered using a Meta Quest 2. Activities include structured, graded tasks and free exploration, with interaction modes adapted to participants' upper-limb functional abilities. Participants continue to receive their usual occupational therapy throughout the study.

    Other: Occupation-Based Immersive Virtual Reality Rehabilitation

Interventions

  • OtherOccupation-Based Immersive Virtual Reality Rehabilitation

    The intervention consists of 12 supervised immersive virtual reality (IVR) sessions using two occupation-based applications: Virtual Gardening and Virtual Painting. Each session is planned to include approximately 30 minutes of virtual activities: 10 minutes of structured Gardening, 10 minutes of structured Painting, 5 minutes of free Gardening, and 5 minutes of free Painting. Gardening activities include reaching toward leaves, harvesting virtual olives, planting seeds, and watering plants. Painting activities include tracing geometric and representational shapes and creating drawings using virtual brushes and colours. The applications provide graded task difficulty, affected-hand interaction, mirrored control using the unaffected hand, and free exploration. Participants interact with the virtual environment using a Meta Quest 2 head-mounted display and controllers while seated, under therapist supervision. Rest breaks and assistance are provided according to individual needs.

06

What researchers measure

Primary outcomes

  1. Intervention Completion Rate

    Percentage of enrolled participants who completed the planned 12-session immersive virtual reality rehabilitation program. Calculated as the number of participants completing the intervention divided by the total number enrolled, multiplied by 100.

    Time frame: From enrollment to completion of the 12-session intervention (approximately 4 weeks per participant).

  2. Session Delivery Rate

    Percentage of planned immersive virtual reality rehabilitation sessions that were delivered. Calculated as the number of sessions delivered divided by the total number of sessions planned across enrolled participants, multiplied by 100.

    Time frame: Throughout the 12-session intervention period (approximately 4 weeks per participant).

Secondary outcomes

  1. Upper-Limb Motor Impairment - Fugl-Meyer Assessment for the Upper Extremity (FMA-UE)

    Change in upper-limb motor impairment assessed using the FMA-UE. The motor function subscale ranges from 0 to 66, with higher scores indicating better upper-limb motor performance. Changes from baseline to the post-intervention assessment will be examined.

    Time frame: Baseline (before intervention) and after session 12 (approximately 4 weeks).

  2. Independence in Activities of Daily Living - Barthel Index(BI)

    Change in independence in basic activities of daily living assessed using the BI. Total scores range from 0 to 100, with higher scores indicating greater functional independence. Changes from baseline to the post-intervention assessment will be examined.

    Time frame: Baseline (before intervention) and after session 12 (approximately 4 weeks).

  3. User Satisfaction - User Satisfaction Evaluation Questionnaire (USEQ)

    Participant-reported satisfaction and user experience with immersive virtual reality, assessed using the USEQ. Responses are rated on a five-point Likert scale, with higher scores on positively worded items indicating greater satisfaction. Discomfort-related items are interpreted separately.

    Time frame: After session 1, after session 6 (approximately 2 weeks), and after session 12 (approximately 4 weeks).

  4. Simulator Sickness Symptoms - Simulator Sickness Questionnaire (SSQ)

    Symptoms associated with virtual reality exposure, including nausea, oculomotor discomfort, and disorientation, assessed using the SSQ. Higher scores indicate greater symptom severity.

    Time frame: After session 1, after session 6 (approximately 2 weeks), and after session 12 (approximately 4 weeks).

  5. Rehabilitation Participation - Pittsburgh Rehabilitation Participation Scale (PRPS)

    Therapist-rated participation during immersive virtual reality rehabilitation sessions, assessed using the PRPS. Scores range from 1 to 6, with higher scores indicating greater participation.

    Time frame: During each intervention session (sessions 1-12), over approximately 4 weeks per participant.

Other outcomes

  1. Documented Gameplay Duration

    Duration of active immersive virtual reality gameplay, recorded in minutes during each intervention session. Descriptive statistics will summarize the documented gameplay duration across delivered sessions.

    Time frame: During each delivered intervention session (sessions 1-12), over approximately 4 weeks per participant.

  2. Technical Interruptions

    Number and proportion of delivered immersive virtual reality sessions affected by technical interruptions, including headset tracking problems, controller connectivity issues, or signal loss.

    Time frame: During each delivered intervention session (sessions 1-12), over approximately 4 weeks per participant.

  3. Adverse Events

    Number and description of adverse events documented during the immersive virtual reality intervention, including symptoms or incidents potentially associated with virtual reality exposure. Events will be summarized descriptively.

    Time frame: From the first intervention session through completion of session 12, approximately 4 weeks per participant.

07

Study locations

2 of 2 sites recruiting
  • Adult Day Care Center Agkaliazhn
    Larissa, Thessaly, Greece
    Recruiting
  • Animus Rehabilitation & Recovery Center
    Larissa, Thessaly, Greece
    Recruiting
    • Fwteinh Kechagia, BSc · Contactinfo@animus.com.gr · +302410851851
    • Dimosthenis Lygouras, MSc · Principal investigator
08

References and documents

Individual participant data

Plan to share: No — The individual participant data generated during this study will not be publicly shared due to participant confidentiality considerations and the small sample size. Aggregated study findings will be reported in the resulting publications.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2026 (actual). Primary completion is estimated for Jul 2027, 18 months after the start.

Of 3,117 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 18 months is below that.

Counting every sponsor, half of 3,261 studies reached it within 23 months; a quarter within 10 and three quarters within 46.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 4, 2026
First posted
Nov 13, 2026
StartActual
Jan 12, 2026
Primary completionEst.
Jul 20, 2027
CompletionEst.
Jul 20, 2027
Last update
Nov 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 13, 2026
Show all 1 update
  1. Nov 13, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07936461
Lead sponsor
Democritus University of Thrace
Responsible party
Dimosthenis Lygouras (Occupational Therapist, MSc, PhD candidate, Democritus University of Thrace) — Principal investigator
First posted
Nov 13, 2026
Start date
Jan 12, 2026
Primary completion
Jul 20, 2027 (estimated)
Completion
Jul 20, 2027 (estimated)
Last update
Nov 13, 2026

Study contacts

Dimosthenis Lygouras, MSc
Contact
dlygoura@cs.duth.gr
+306982897261

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion